extension

Obtain

Obtain mechanistic understanding and novel insights into disease biology.
speed

Speed up

Speed up your early R&D process and reduce your time to decision making.
saved_search

Identify

Identify targets and lead compounds with potential to produce first-in-class medicines.
Our services

An approach you can trust

We are seasoned specialists in providing neurobiology research services. Our mission is to create groundbreaking in vitro concepts that will advance the neuroscience research field and enable our Clients to conduct successful drug discovery programs.
Read more arrow_forward
biotech

Basic research

From deciphering disease mechanisms to exploration of novel assay concepts.
ads_click

Target discovery

Using functional genomics and advanced in vitro models we help our Clients to identify and validate novel targets.
query_stats

Lead discovery

Phenotypic and target-based assay development, screening and lead optimization.
Our platform

Elevated neurobiology in vitro research

What sets us apart from the competition is our unique discovery platform. By combining drug discovery expertise and disease area knowledge with cutting-edge technologies, we create complex disease models and assays for functional and morphological screening.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news and to learn about upcoming events.

Read more

News
2024-02-20
Dr. Jonathan Levenson joins Cellectricon’s advisory board
Cellectricon has appointed Dr. Jonathan Levenson, Chief Scientific Officer at FireCyte Therapeutics, to its Scientific Advisory Board. Dr. Levenson brings...
News
2024-02-15
Cellectricon’s expertise in pain research recognized by second EU research grant
MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has received follow-on funding for bone pain research...
Events
March 5-9, 2024
AD/PD 2024
The AD/PD 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Lisbon, Portugal on...
News
2024-02-05
Senior Scientist, high content imaging and analysis
Cellectricon is an innovative discovery services provider with a focus on the neurobiology of peripheral and central nervous system diseases....
Events
February 8, 2024
Webcast - Tools for discovery of novel targets and molecules involved in neuroplasticity
Webcast Description: The incidence of neuropsychiatric disorders has increased dramatically over the past decades, necessitating continued efforts to identify drugs...
News
2024-01-03
New publication: A Microfluidic High-Capacity Screening Platform for Neurological Disorders
We are happy to announce the publication of “A Microfluidic High-Capacity Screening Platform for Neurological Disorders”. In the paper, published...
News
2023-10-19
Cellectricon receives CIR (French Research Tax Credit) accreditation
MÖLNDAL, SWEDEN Cellectricon AB, a services provider dedicated to advancing neuroscience drug discovery, today announced that it has received CIR...
News
2023-09-26
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Mölndal, Sweden Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of a new service...
News
2023-02-14
Delix Therapeutics partners with Cellectricon, Expressive Neuroscience and expands science team to accelerate drug discovery and translatability
We’re excited to be working with Delix Therapeutics and support their development of neuroplasticity-promoting therapeutics! At Cellectricon, we solve our...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Social media

Cellectricon on LinkedIn

Follow us on LinkedIn

Webcasts and videos

Check out our YouTube channel to view select webcasts and presentations from our in-house experts and collaborators.

Follow us on YouTube